BioCryst Pharmaceuticals
BCRX
#4758
Rank
โ‚น218.55 B
Marketcap
โ‚น859.89
Share price
2.38%
Change (1 day)
12.28%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -โ‚น43.49 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น0.88 Billion. In 2025 the company made an earning of โ‚น25.49 Billion, an increase over its 2024 earnings that were of -โ‚น8.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น43.49 Billion-270.6%
2025 โ‚น25.49 B-407.51%
2024 -โ‚น8.29 Billion-61.56%
2023 -โ‚น21.57 Billion-7.43%
2022 -โ‚น23.3 Billion34.42%
2021 -โ‚น17.34 Billion-0.55%
2020 -โ‚น17.43 Billion67.88%
2019 -โ‚น10.39 Billion7.55%
2018 -โ‚น9.66 Billion53.92%
2017 -โ‚น6.28 Billion19.29%
2016 -โ‚น5.26 Billion28.19%
2015 -โ‚น4.11 Billion-4.8%
2014 -โ‚น4.31 Billion50.09%
2013 -โ‚น2.88 Billion-23.29%
2012 -โ‚น3.75 Billion-26.19%
2011 -โ‚น5.07 Billion54.78%
2010 -โ‚น3.28 Billion150.1%
2009 -โ‚น1.31 Billion-49.43%
2008 -โ‚น2.59 Billion14.07%
2007 -โ‚น2.28 Billion-49.31%
2006 -โ‚น4.48 Billion72.87%
2005 -โ‚น2.6 Billion22.08%
2004 -โ‚น2.13 Billion75.3%
2003 -โ‚น1.22 Billion-25.36%
2002 -โ‚น1.63 Billion225.05%
2001 -โ‚น0.5 Billion-56.6%
2000 -โ‚น1.15 Billion50.63%
1999 -โ‚น0.77 Billion38.05%
1998 -โ‚น0.56 Billion-52.46%
1997 -โ‚น1.17 Billion58.44%
1996 -โ‚น0.74 Billion-14.44%
1995 -โ‚น0.86 Billion28.57%
1994 -โ‚น0.67 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚น1.022 T-2,462.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น954.40 B-2,304.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น2.33 B-105.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น7.44 B-117.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น6.15 Billion-85.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น29.47 Billion-31.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น0.78 Billion-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น2.12 Billion-95.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น5.63 B-113.01%๐Ÿ‡บ๐Ÿ‡ธ USA